Magnolia Capital Advisors LLC Abbott Laboratories Transaction History

Magnolia Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$100.73 - $112.44 $304,305 - $339,681	3,021 New	3,021 $313,000
Q4 2023 Feb 02, 2024	BUY	$90.19 - $110.4 $249,826 - $305,808	2,770 New	2,770 $304,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $47,655 - $56,092	-492 Reduced 15.91%	2,601 $263,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $294,020 - $344,931	3,093 New	3,093 $340,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $192,237 - $234,421	-1,686 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $194,783 - $238,501	1,686 New	1,686 $237,000

3,224

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Magnolia Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Magnolia Capital Advisors LLC with notifications on news.